CLINICAL_TRIALS
trial_result
· 2016-02-02
Clinical Trial Update: A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa [Phase 4]
Summary
Phase 4, double-blind, placebo-controlled trial evaluating risperidone for anorexia nervosa has completed. Results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Anorexia Nervosa | Phase 4 | Status: COMPLETED | Results posted: 2016-02-02